Assignee
NINGBO COMBIREG PHARMACEUTICAL TECH CO LTD
CN·1 granted patent·1 pending application·0 citations·filing 2021–2022
Top patents by PatentIndex Score
2 records- 0155US2024423971A1Application of rip2 inhibitor combined with chemotherapy drugNINGBO COMBIREG PHARMACEUTICAL TECH CO LTD·Filed 2022·Application pending·0 cites
- 0243US12577213B2Deuterated 1,4-benzodiazepine-2,5-dione compound and use thereofNINGBO COMBIREG PHARMACEUTICAL TECH CO LTD·Filed 2021·Granted Mar 17, 2026·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when NINGBO COMBIREG PHARMACEUTICAL TECH CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →